US Stock MarketDetailed Quotes

ANTX AN2 Therapeutics

Watchlist

1.050
-0.020-1.87%

Close Oct 1 16:00 ET

1.050
0.0000.00%

Pre 08:00 ET

31.33MMarket Cap-481P/E (TTM)

AN2 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

9.74%104.54M

29.03%114.21M

11.70%107.3M

18.62%123.82M

-15.99%95.26M

-25.21%88.52M

64.05%96.06M

--104.38M

-Cash and cash equivalents

-34.41%26.77M

-7.55%24.69M

-42.51%15.65M

13.24%32.62M

0.48%40.81M

-67.63%26.71M

125.01%27.22M

--28.8M

-Short-term investments

42.84%77.77M

44.84%89.52M

33.13%91.65M

20.67%91.2M

-25.18%54.45M

72.47%61.81M

48.18%68.84M

--75.58M

Other current assets

-1.70%2.9M

16.77%2.1M

25.37%3.21M

-11.08%2.59M

-15.48%2.95M

26.03%1.8M

65.18%2.56M

--2.91M

Total current assets

9.40%107.44M

28.78%116.31M

12.05%110.51M

17.81%126.41M

-15.97%98.21M

-24.60%90.32M

64.08%98.62M

--107.3M

Non current assets

Investments and advances

--0

--3.9M

744.80%27.19M

1,223.09%26.36M

--0

-7.66%3.22M

--1.99M

Non current deferred assets

----

--48K

----

--0

Other non current assets

44.86%1.04M

0.00%720K

--720K

Total non current assets

44.86%1.04M

544.14%4.95M

616.86%28.24M

910.29%27.4M

-77.06%720K

6.67%768K

-24.40%3.94M

--2.71M

Total assets

9.66%108.48M

33.13%121.26M

35.28%138.74M

39.82%153.81M

-17.57%98.93M

-24.41%91.08M

57.02%102.56M

--110.01M

Liabilities

Current liabilities

Payables

-39.80%1.89M

-31.37%2.43M

26.11%2.68M

238.68%4.88M

94.23%3.13M

35.88%3.55M

99.62%2.12M

--1.44M

-accounts payable

-39.80%1.89M

-31.37%2.43M

26.11%2.68M

238.68%4.88M

94.23%3.13M

35.88%3.55M

99.62%2.12M

--1.44M

Current accrued expenses

-9.31%5.84M

63.03%6.91M

135.50%6.68M

276.18%6.79M

257.55%6.44M

101.86%4.24M

102.79%2.84M

--1.81M

Current debt and capital lease obligation

----

0.00%13K

6.25%34K

--53K

--73K

-Current capital lease obligation

----

--0

0.00%13K

6.25%34K

--53K

--73K

Other current liabilities

18,533.33%559K

6,320.00%321K

11,033.33%668K

12,100.00%976K

-66.67%3K

-50.00%5K

-64.71%6K

--8K

Current liabilities

-9.26%10.13M

24.48%10.66M

95.42%14.04M

234.81%14.84M

169.00%11.16M

68.39%8.57M

111.66%7.19M

--4.43M

Non current liabilities

Derivative product liabilities

----

--0

-75.00%1K

-83.33%1K

-84.62%2K

--3K

Total non current liabilities

--0

-75.00%1K

-83.33%1K

-84.62%2K

--3K

Total liabilities

-9.27%10.13M

24.47%10.66M

95.37%14.04M

234.59%14.84M

168.77%11.16M

68.21%8.57M

110.92%7.19M

--4.44M

Shareholders'equity

Share capital

--0

-common stock

--0

-Preferred stock

--0

Retained earnings

-53.50%-185.51M

-62.85%-171.07M

-72.15%-154.46M

-76.62%-137.56M

-81.61%-120.85M

-86.18%-105.05M

-89.35%-89.72M

---77.88M

Paid-in capital

36.01%283.89M

50.00%281.62M

50.37%278.88M

50.36%276.65M

14.21%208.73M

9.16%187.74M

--185.47M

--184M

Gains losses not affecting retained earnings

77.31%-27K

130.29%53K

173.53%275K

77.45%-122K

66.94%-119K

-10.76%-175K

-1,285.19%-374K

---541K

Total stockholders'equity

12.07%98.35M

34.03%110.6M

30.75%124.7M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

54.05%95.37M

--105.57M

Total equity

12.07%98.35M

34.03%110.6M

30.75%124.7M

31.63%138.97M

-24.25%87.76M

-28.50%82.52M

54.05%95.37M

--105.57M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	9.74%104.54M	29.03%114.21M	11.70%107.3M	11.70%107.3M	18.62%123.82M	-15.99%95.26M	-25.21%88.52M	64.05%96.06M	64.05%96.06M	--104.38M
-Cash and cash equivalents	-34.41%26.77M	-7.55%24.69M	-42.51%15.65M	-42.51%15.65M	13.24%32.62M	0.48%40.81M	-67.63%26.71M	125.01%27.22M	125.01%27.22M	--28.8M
-Short-term investments	42.84%77.77M	44.84%89.52M	33.13%91.65M	33.13%91.65M	20.67%91.2M	-25.18%54.45M	72.47%61.81M	48.18%68.84M	48.18%68.84M	--75.58M
Other current assets	-1.70%2.9M	16.77%2.1M	25.37%3.21M	25.37%3.21M	-11.08%2.59M	-15.48%2.95M	26.03%1.8M	65.18%2.56M	65.18%2.56M	--2.91M
Total current assets	9.40%107.44M	28.78%116.31M	12.05%110.51M	12.05%110.51M	17.81%126.41M	-15.97%98.21M	-24.60%90.32M	64.08%98.62M	64.08%98.62M	--107.3M
Non current assets
Investments and advances	--0	--3.9M	744.80%27.19M	744.80%27.19M	1,223.09%26.36M	--0	--0	-7.66%3.22M	-7.66%3.22M	--1.99M
Non current deferred assets	----	----	----	----	----	----	--48K	----	----	--0
Other non current assets	44.86%1.04M	44.86%1.04M	44.86%1.04M	44.86%1.04M	44.86%1.04M	0.00%720K	0.00%720K	--720K	--720K	--720K
Total non current assets	44.86%1.04M	544.14%4.95M	616.86%28.24M	616.86%28.24M	910.29%27.4M	-77.06%720K	6.67%768K	-24.40%3.94M	-24.40%3.94M	--2.71M
Total assets	9.66%108.48M	33.13%121.26M	35.28%138.74M	35.28%138.74M	39.82%153.81M	-17.57%98.93M	-24.41%91.08M	57.02%102.56M	57.02%102.56M	--110.01M
Liabilities
Current liabilities
Payables	-39.80%1.89M	-31.37%2.43M	26.11%2.68M	26.11%2.68M	238.68%4.88M	94.23%3.13M	35.88%3.55M	99.62%2.12M	99.62%2.12M	--1.44M
-accounts payable	-39.80%1.89M	-31.37%2.43M	26.11%2.68M	26.11%2.68M	238.68%4.88M	94.23%3.13M	35.88%3.55M	99.62%2.12M	99.62%2.12M	--1.44M
Current accrued expenses	-9.31%5.84M	63.03%6.91M	135.50%6.68M	135.50%6.68M	276.18%6.79M	257.55%6.44M	101.86%4.24M	102.79%2.84M	102.79%2.84M	--1.81M
Current debt and capital lease obligation	----	----	----	----	----	0.00%13K	6.25%34K	--53K	--53K	--73K
-Current capital lease obligation	----	----	--0	--0	--0	0.00%13K	6.25%34K	--53K	--53K	--73K
Other current liabilities	18,533.33%559K	6,320.00%321K	11,033.33%668K	11,033.33%668K	12,100.00%976K	-66.67%3K	-50.00%5K	-64.71%6K	-64.71%6K	--8K
Current liabilities	-9.26%10.13M	24.48%10.66M	95.42%14.04M	95.42%14.04M	234.81%14.84M	169.00%11.16M	68.39%8.57M	111.66%7.19M	111.66%7.19M	--4.43M
Non current liabilities
Derivative product liabilities	----	----	--0	--0	--0	-75.00%1K	-83.33%1K	-84.62%2K	-84.62%2K	--3K
Total non current liabilities	--0	--0	--0	--0	--0	-75.00%1K	-83.33%1K	-84.62%2K	-84.62%2K	--3K
Total liabilities	-9.27%10.13M	24.47%10.66M	95.37%14.04M	95.37%14.04M	234.59%14.84M	168.77%11.16M	68.21%8.57M	110.92%7.19M	110.92%7.19M	--4.44M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-53.50%-185.51M	-62.85%-171.07M	-72.15%-154.46M	-72.15%-154.46M	-76.62%-137.56M	-81.61%-120.85M	-86.18%-105.05M	-89.35%-89.72M	-89.35%-89.72M	---77.88M
Paid-in capital	36.01%283.89M	50.00%281.62M	50.37%278.88M	50.37%278.88M	50.36%276.65M	14.21%208.73M	9.16%187.74M	--185.47M	--185.47M	--184M
Gains losses not affecting retained earnings	77.31%-27K	130.29%53K	173.53%275K	173.53%275K	77.45%-122K	66.94%-119K	-10.76%-175K	-1,285.19%-374K	-1,285.19%-374K	---541K
Total stockholders'equity	12.07%98.35M	34.03%110.6M	30.75%124.7M	30.75%124.7M	31.63%138.97M	-24.25%87.76M	-28.50%82.52M	54.05%95.37M	54.05%95.37M	--105.57M
Total equity	12.07%98.35M	34.03%110.6M	30.75%124.7M	30.75%124.7M	31.63%138.97M	-24.25%87.76M	-28.50%82.52M	54.05%95.37M	54.05%95.37M	--105.57M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data